IN190388B - - Google Patents

Info

Publication number
IN190388B
IN190388B IN2930DE1998A IN190388B IN 190388 B IN190388 B IN 190388B IN 2930DE1998 A IN2930DE1998 A IN 2930DE1998A IN 190388 B IN190388 B IN 190388B
Authority
IN
India
Prior art keywords
active compound
biologically active
vesicles
mlcvs
multilamellar
Prior art date
Application number
Other languages
English (en)
Inventor
Lawrence Boni
Michael Batenjany
Stella Gevantmakher
Original Assignee
Biomira Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomira Usa Inc filed Critical Biomira Usa Inc
Publication of IN190388B publication Critical patent/IN190388B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y10S977/907—Liposome

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IN2930DE1998 1997-10-01 1998-01-01 IN190388B (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6060697P 1997-10-01 1997-10-01

Publications (1)

Publication Number Publication Date
IN190388B true IN190388B (fr) 2003-07-26

Family

ID=22030591

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2930DE1998 IN190388B (fr) 1997-10-01 1998-01-01

Country Status (9)

Country Link
US (1) US6544549B1 (fr)
EP (1) EP1019026B1 (fr)
JP (1) JP2001517693A (fr)
AT (1) ATE286717T1 (fr)
AU (1) AU745000B2 (fr)
CA (1) CA2305533C (fr)
DE (1) DE69828624T2 (fr)
IN (1) IN190388B (fr)
WO (1) WO1999016426A2 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2006095798A1 (ja) * 2005-03-09 2008-08-14 サンスター株式会社 フィトステロールを含んだリポソームを含有する抗癌用経口組成物、該リポソームによる癌の予防又は治療
WO2007021822A2 (fr) * 2005-08-09 2007-02-22 The Research Foundation Of State Of University Of New York At Buffalo Compositions et procedes de preparation d'il-12 microparticulaire liposomale
WO2008005045A2 (fr) 2005-12-30 2008-01-10 Dermazone Solutions, Inc. Nanoparticules lipidiques
US20140271782A1 (en) 2013-03-15 2014-09-18 Dermazone Solutions, Inc. Method for preparing nanolipids with encapsulated alcohol
EP3936122A1 (fr) 2008-11-24 2022-01-12 Massachusetts Institute Of Technology Procédés et compositions pour l'administration localisée d'un agent
US20100323018A1 (en) * 2009-06-17 2010-12-23 Massachusetts Institute Of Technology Branched DNA/RNA monomers and uses thereof
US20100324124A1 (en) * 2009-06-17 2010-12-23 Massachusetts Institute Of Technology Compositions and methods relating to DNA-based particles
WO2011115684A2 (fr) * 2010-03-19 2011-09-22 Massachusetts Institute Of Technology Compositions de vésicules lipidiques et procédés pour les utiliser
US9149432B2 (en) 2010-03-19 2015-10-06 Massachusetts Institute Of Technology Lipid vesicle compositions and methods of use
US20110229556A1 (en) * 2010-03-19 2011-09-22 Massachusetts Institute Of Technology Lipid-coated polymer particles for immune stimulation
CN102654505A (zh) * 2012-05-16 2012-09-05 江苏省原子医学研究所 一种检测il-2-hsa的时间分辨荧光免疫分析试剂盒及其检测方法
WO2014068085A1 (fr) * 2012-11-02 2014-05-08 Cytuvax Composition comprenant des macro-agrégats de cytokine
US9770415B2 (en) * 2012-11-27 2017-09-26 Southwest Research Institute Delivery substrates from aligned polymer biomaterials for tissue repair
CA2925304C (fr) 2013-09-27 2023-04-18 Massachusetts Institute Of Technology Nanostructures proteiques biologiquement actives sans entraineur
JP6715265B2 (ja) 2015-05-04 2020-07-01 フェルザンティス アーゲーＶｅｒｓａｎｔｉｓ Ａｇ 膜内外ｐＨ勾配ベシクルを調製する方法
WO2017027843A1 (fr) 2015-08-12 2017-02-16 Massachusetts Institute Of Technology Couplage de nanoparticules à la surface cellulaire
EP3468581A1 (fr) 2016-06-13 2019-04-17 Torque Therapeutics, Inc. Méthodes et procédés pour favoriser la fonction des cellules immunitaires
CN111432836A (zh) 2017-09-05 2020-07-17 转矩医疗股份有限公司 治疗性蛋白质组合物及其制备和使用方法
US20200078427A1 (en) 2018-09-06 2020-03-12 NuVessl, Inc. Cannabis Sativa Derived Formulation for Transmucosal and Transdermal Delivery
US20200188298A1 (en) 2018-12-14 2020-06-18 NuVessl, Inc. Method For Using Composition With Enhanced Passenger Molecule Loading
US20230096704A1 (en) * 2020-02-05 2023-03-30 University Of Florida Research Foundation, Incorporated Rna-loaded nanoparticles and use thereof for the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04356421A (ja) 1991-03-06 1992-12-10 Green Cross Corp:The プロスタグランジン類含有脂肪小体組成物
WO1997029769A1 (fr) * 1996-02-16 1997-08-21 Biomira Usa Inc. Vaccin contre des malignites affectant les lymphocytes b

Also Published As

Publication number Publication date
AU745000B2 (en) 2002-03-07
EP1019026B1 (fr) 2005-01-12
EP1019026A2 (fr) 2000-07-19
JP2001517693A (ja) 2001-10-09
AU9680098A (en) 1999-04-23
DE69828624T2 (de) 2005-12-22
WO1999016426A2 (fr) 1999-04-08
DE69828624D1 (de) 2005-02-17
WO1999016426A3 (fr) 1999-06-17
ATE286717T1 (de) 2005-01-15
CA2305533C (fr) 2009-12-01
US6544549B1 (en) 2003-04-08
CA2305533A1 (fr) 1999-04-08

Similar Documents

Publication Publication Date Title
IN190388B (fr)
ATE341310T1 (de) Dehydratisierungs-/rehydratisierungsverfahren zur herstellung von liposome
WO2000045791A3 (fr) Procede servant a preparer des liposomes de dimensions selectionnees
AU8141891A (en) Unilamellar vesicles
NZ334561A (en) Preparation of multivesicular liposomes for controPreparation of multivesicular liposomes for controlled release of active agents lled release of active agents
AU6036596A (en) Process for making liposome preparation
HUP9802578A3 (en) Phenylacetic acid derivatives, process and intermediates for producing them, fingicide, insecticide, arachnicide and nematocide compositions containing these compounds as active ingredients and use thereof
CA2108288A1 (fr) Formulation cyclorosporine liposomal et procede de preparation
CA2138925A1 (fr) Methode pour la production de lipoproteines reconstituees
CA2227761A1 (fr) Procedes de fabrication des liposomes contenant des photosensibilisateurs d'hydro-monobenzoporphyrine
NZ503293A (en) Liposomal camptothecin formulations also comprising at least one phospholipid
WO2003000227A3 (fr) Procede de preparation de vesicules chargees d'un materiau biologique et differentes utilisations desdites vesicules
ES2074878T3 (es) Polvo preliposomal de polieno liposomal y metodo para su preparacion.
JP2001517693A5 (fr)
CA2187748A1 (fr) Liposomes de fusion, leurs procedes de preparation et d'utilisation
MY131524A (en) Liposomal itraconazole formulations
CA2202103A1 (fr) Methode de preparation d'une vesicule fermee
GB2303791A (en) Method of preparing a predetermined active agent stock solution for liposomal microencapsulation of active agents for agricultural uses
AU651969B2 (en) Process for the production of aqueous liposome suspensions containing active ingredients
CA2101325A1 (fr) Agents acellulaires et cellulaires de nucleation de la glace et procede pour leur production
EP0382777A4 (en) Aqueous preparation of liposome composition
JPS5344559A (en) New urethanes and their preparation
ES2168351T3 (es) Preparaciones farmaceuticas que contienen nifedipina y procedimiento para su preparacion.
TH58479B (th) สารผสมสำหรับใช้ทางปากต้านแบคทีเรียชนิดลิวพูโลนที่ถูกไฮโดรจีเนตและคงตัว